Trial Profile
Single-Arm Phase II Study of Stereotactic Body Radiation Therapy Concurrent With Nelfinavir for Oligometastases
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jul 2021
Price :
$35
*
At a glance
- Drugs Nelfinavir (Primary)
- Indications Cancer metastases
- Focus Therapeutic Use
- 26 Mar 2021 Status changed from active, no longer recruiting to completed.
- 20 Jul 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2020.
- 08 Jun 2016 Status changed from recruiting to active, no longer recruiting.